PAVmed (PAVMW) Stock Analysis
NASDAQHealthcareMedical - Devices
What PAVmed does
PAVmed Inc. is a U.S.-based company that develops and commercializes innovative medical technologies. Its core product offerings include CarpX, a minimally invasive device designed for treating carpal tunnel syndrome, and EsoCheck, an advanced system for collecting esophageal cells to aid in the early identification of esophageal adenocarcinoma and Barrett's Esophagus (BE). The company's robust development pipeline further encompasses EsoGuard, a molecular diagnostic test utilizing esophageal DNA; EsoCure, an ablation device targeting dysplastic BE; PortIO, an implantable solution for intraosseous vascular access; NextFlo, a disposable infusion platform; and DisappEAR, a resorbable ear tube for pediatric use. Additional projects in their portfolio include NextCath and Caldus. Established in 2014 and headquartered in New York, New York, the firm initially operated under the name PAXmed Inc. before rebranding as PAVmed Inc. in April 2015.
Key metrics
ETFs linked to PAVMW
Broad-market and Healthcare sector ETFs an investor holding PAVmed is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how PAVMW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze PAVMW in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for PAVmed?
- PAVmed trades under the ticker PAVMW on NASDAQ.
- Which exchange is PAVMW listed on?
- PAVMW is listed on NASDAQ.
- What sector does PAVmed operate in?
- PAVmed is classified in the Healthcare sector (Medical - Devices industry).
- How can PortView help analyze PAVMW in a portfolio?
- PortView shows PAVMW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.